Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

News zum Sektor Gesundheit aus China

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 100 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1574 Aktien zum Sektor Gesundheit bekannt.
 
04.07.25 - 10:15
Full-day Takeaway: HSI Closes at 23,916, Down 153 pts; HSTI Closes at 5,216, Down 17 pts; ALI HEALTH Down over 6%; CCB, J&T EXPRESS-W, AKESO, MINSHENG BANK, XD INC Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 153 pts or 0.6% to 23,916. HSTI dropped 17 pts or 0.3% to 5,216. HSCEI fell 39 pts or 0.5% to 8,609. Market turnover reached $267.81 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $120.8, down 1.6%BABA (09988.HK) closed at $105.1, down 1%XIAOMI (01810.HK) closed at $57.5, down 1%TENCENT (00700.HK)......
04.07.25 - 06:15
Midday Takeaway: HSI Closes Midday at 23,921, Down 148 pts; HSTI Closes Midday at 5,209, Down 24 pts; ALI HEALTH Down over 6%; AKESO, KB LAMINATES Hit New Highs (AAStocks)
 
At midday close, HSI dropped 148 pts or 0.6% to 23,921. HSTI dropped 24 pts or 0.5% to 5,209. HSCEI fell 36 pts or 0.4% to 8,611.Active Heavyweights:XIAOMI (01810.HK) closed at $57.4, down 1.2%MEITUAN (03690.HK) closed at $121.7, down 0.9%PING AN (02318.HK) closed at $49.7, down 0.8%HKEX (00388.HK) closed at $414.8, down 0.6%BAB......
04.07.25 - 02:33
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China (PR Newswire)
 
Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING,......
03.07.25 - 16:00
Zacks.com featured highlights include Hudbay Minerals, StoneCo, Centene and CVS Health (Zacks)
 
HBM, STNE, CNC, and CVS stand out for low P/CF ratios and strong value scores as investors seek quality in a cautious market....
03.07.25 - 12:30
HKD3.2B Southbound Trading Net Outflow from BABA-W (AAStocks)
 
There was HKD987.4 million and HKD22.7 million Southbound Trading net inflow to MEITUAN-W (03690.HK) and XIAOMI-W (01810.HK).There was HKD3.2 billion, HKD885.3 million and HKD739.9 million Southbound Trading net outflow from BABA-W (09988.HK), TENCENT (00700.HK) and AKESO (09926.HK).For Southbound Trading of Shanghai-Hong Kong S......
03.07.25 - 10:33
HUTCHMED to Announce 2025 Half-Year Financial Results (GlobeNewswire EN)
 
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 03, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2025 on Thursday, August 7, 2025 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT)....
03.07.25 - 10:15
Full-day Takeaway: HSI Closes at 24,069, Down 151 pts; HSTI Closes at 5,233, Down 35 pts; XIAOMI Down over 3%; ZIJIN MINING, AKESO, KB LAMINATES, ASCENTAGE, GLOBAL NEW MAT Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 151 pts or 0.6% to 24,069. HSTI dropped 35 pts or 0.7% to 5,233. HSCEI fell 76 pts or 0.9% to 8,648. Market turnover reached $231.25 billion.Active Heavyweights:XIAOMI (01810.HK) closed at $58.1, down 3.4%BABA (09988.HK) closed at $106.2, down 2.9%MEITUAN (03690.HK) closed at $122.8, down 2.5%HKEX (00388.HK......
03.07.25 - 08:51
Akeso′s First Bispecific ADC (Trop2/Nectin4 ADC) Enters Clinical Trials, Strengthening Leadership in ′IO+ADC′ 2.0 Strategy (PR Newswire)
 
HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a bispecific Antibody-Drug Conjugate (ADC) targeting Trop2 and Nectin4. AK146D1 is Akeso's......
03.07.25 - 06:30
Midday Takeaway: HSI Closes Midday at 23,989, Down 232 pts; HSTI Closes Midday at 5,205, Down 63 pts; XIAOMI Down over 4%; BABA Down over 3%; HENDERSON LAND, XINYI ENERGY, ASCENTAGE, GLOBAL NEW MAT, GREAT EAGLE H Hit New Highs (AAStocks)
 
At midday close, HSI dropped 232 pts or 1.0% to 23,989. HSTI dropped 63 pts or 1.2% to 5,205. HSCEI fell 108 pts or 1.2% to 8,616.Active Heavyweights:XIAOMI (01810.HK) closed at $57.5, down 4.4%BABA (09988.HK) closed at $105.5, down 3.6%MEITUAN (03690.HK) closed at $122.9, down 2.5%HKEX (00388.HK) closed at $417.6, down 1.3%TENC......
03.07.25 - 02:33
Jacobio′s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted (PR Newswire)
 
BEIJING, SHANGHAI and BOSTON, July 2, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseases to the Center for Drug Evaluation (CDE) in......
03.07.25 - 01:03
Ascletis Announces First Participants with Obesity or Overweight Dosed in a U.S. 13-week Phase IIa Study of Small Molecule Oral GLP-1R Agonist ASC30 (PR Newswire)
 
- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week Phase IIa study of small molecule oral GLP-1 receptor agonist ASC30. - ASC30 oral once-daily tablet demonstrated up to 6.5% placebo-adjusted mean body weight......
02.07.25 - 18:15
4 Value Stocks to Invest in for the Second-Half 2025 Market Shift (Zacks)
 
Hudbay, StoneCo, Centene, and CVS stand out as top value picks for H2 2025 with strong cash flow and growth prospects....
02.07.25 - 12:42
China′s Skyworth to take over Philips brand TVs in US from Funai (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
02.07.25 - 09:00
Research: M Stanley Initiates Coverage on HENGRUI PHARMA w/ Overweight Rating, $78 TP (AAStocks)
 
Morgan Stanley released a research report, covering HENGRUI PHARMA (01276.HK), which possesses the most extensive and balanced product portfolio and pipeline among domestic pharmaceutical companies in China. The company estimated to have 47 new drugs approved for market launch between 2025 and 2027. Since 2018, the company has e......
02.07.25 - 06:45
Research: Citi Raises INNOVENT BIO's TP to HKD90; New Phase Begins (AAStocks)
 
INNOVENT BIO (01801.HK)'s IBI363 (PD-1/IL-2alpha-bias bispecific antibody fusion protein product) has been highlighted by opinion leaders for its promising data and potential to become a key product in next-generation immuno-oncology (IO) treatment, Citi published a research report noting.In Citi's opinion, INNOVENT BIO ......
02.07.25 - 06:30
Research: Citi: CN Issues Several Measures to Support High-Quality Development of Innovative Drugs, Benefiting Sector; Top Pick HANSOH PHARMA (AAStocks)
 
China's National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) jointly issued the 'Several Measures to Support the High-Quality Development of Innovative Drugs' on 1 July, marking the first time the two government departments have jointly introduced policies to support differentia......
02.07.25 - 05:30
On Move: SIPAI HEALTH Once Hyped Up 49% w/ Turnover Surpassing HKD1B (AAStocks)
 
SIPAI HEALTH (00314.HK) opened sharply higher by 14.2% this morning (2nd) and once climbed to an over three-month high of HKD6.93 with a surge of 49.4% in early trading. It last traded at HKD5.91, up 27.37%, with a volume surging to 167 million shares, involving HKD1.058 billion, making it one of the top 20 most active stocks by......
01.07.25 - 13:48
Hutchmed to get milestone payment after China drug approval (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
01.07.25 - 13:45
Zura Bio appoints Eric Hyllengren as CFO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.07.25 - 12:36
Zura Bio Announces Chief Financial Officer Transition (Business Wire)
 
HENDERSON, Nev.--(BUSINESS WIRE)--$ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 7, 2025. He will succeed Verender Badial, who will step down from the role and remain with the company as a non-executive employee through July 31, 2025, to support a seamless transition. Mr. Badial joined Zura Bio in March 2023, at the time of its business combination with JATT Acquisition Corporation. He led the development of Zura Bio's internal financial and operational systems, contributed to shaping its financial strategy, and participated in capital-raising efforts that supported the company's early growth. Mr. Hyllengren brings over 20 years of financial leadership experience in the life sciences and biotechnology sectors. He most recently served as Chief Operatin...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!